Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Moligand™, 10mM in DMSO Moligand™ for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 3 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Information
Anastrozole (ZD-1033) Anastrozole (ZD-1033) is a third-generation nonsteroidal selective aromatase inhibitor. It may offer greater selectivity compared with other aromatase inhibitors, being without any intrinsic endocrine effects and with no apparent e
In vitro
Anastrozole has high intrinsic potency in vitro and inhibits human placental aromatase with an IC50 of 15 nM. Anastrozole it is 200 times as potent as AG, twice as potent as 4-OHA and one third as potent as fadrozole. . Anastrozole inhibits aromatase by binding competitively to the hem group of the CYP unit of the enzyme thereby reducing estrogen biosynthesis in the periphery and the breast. Anastrozole has little or no effect on other steroid hormones.
In vivo
Anastrozole (0.1 mg/kg) given orally to mature rats on Day 2 or 3 of the estrous cycle, blocked ovulation in mature females; in pubertal rats, the same dose given for 3 days completely blocks androstenedione-stimulated uterine development. These effects may be attributes to inhibition of the normal preovulatory rise in ovarian follicular estrogen synthesis in mature females and to inhibition of metabolism of the exogenous androstenedione by the immature ovary in prepubertal females. Twice-daily administration of >9.1 mg/kg of Anastrozole given orally to male pigtailed monkeys inhibits peripheral aromatase, thereby reducing circulating estradiol concentrations by 50% to 60%.
Cell Data
cell lines:Neurons
Concentrations:
Incubation Time:
Powder Purity:≥97%
| ALogP | 2.1 |
|---|
| Isómeros SMILES | CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N |
|---|---|
| WGK Alemania | 3 |
| RTECS | CZ1465000 |
| Peso molecular | 293.37 |
| Reaxy-Rn | 8005958 |
| Reaxys-RN_link_address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=8005958&ln= |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| 1. Luo Yu-Wei, Zhou Jiang-Peng, Ji Hongyu, Xu Doudou, Zheng Anqi, Wang Xin, Dai Zhizheng, Luo Zhicheng, Cao Fang, Wang Xing-Yue, Bai Yunfang, Chen Di, Chen Yueming, Wang Qi, Yang Yaying, Zhang Xinghai, Chiu Sandra, Peng Xiaozhong, Huang Ai-Long, Tang Kai-Fu. (2024) SARS-CoV-2 N protein-induced Dicer, XPO5, SRSF3, and hnRNPA3 downregulation causes pneumonia. Nature Communications, 15 (1): (1-23). [PMID:39138195] [10.1038/s41467-024-51192-1] |
| 2. Tiantian Fu, Bingyi Yao, Yuanqing Guo, Yujia Yang, Junze Huang, Chenmeizi Liang, Yuanjin Zhang, Xin Wang. (2025) Metabolism of nifedipine by placental CYP19A1 and competitive inhibition by chlorpromazine. BIOCHEMICAL PHARMACOLOGY, [PMID:41110490] [10.1016/j.bcp.2025.117425] |
| 3. Le-hao Jin, Zhe-yan Zhang, Xiao-yu Xu, Zhong-xi Chen, Jing Chen, Yu-bin Lan, Liu-liu Pan, Xiao-dan Zhang. (2026) The Inhibitory Effect of Anastrozole on the Metabolism of Abemaciclib In Vitro and In Vivo. ACS Omega, [PMID:] [10.1021/acsomega.6c00144] |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Moligand™ grade guide →